Supplements for pain management

Details Supplements for pain management Supplements for pain management

2011-01-18

2011-01-18

Davis, Ruth A (Department: 1651)

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

C424S094630, C424S094600, C424S094100, C424S400000

Reexamination Certificate

active

07871609

ABSTRACT:
Dietary supplements, compositions and methods of administering the supplements to reduce pain, inflammation and stiffness in said mammal within a few hours. The supplements and compositions can include a combination of an amino acid, vitamins, herbs and enzymes. The composition/supplement can be put in capsule form and when administered to mammals can reduce these symptoms within approximately two hours. reducing the pain and inflammation associated with chronic joint discomfort, chronic low back pain, muscle strain, arthritis, sports injuries, normal everyday bumps and bruises. The novel composition has also been shown to be very effective in reducing monthly menstrual symptoms (PMS). The novel composition can also have benefits for other ailments such as but not limited to Osteoarthritis, Cardiovascular disease, Neurological ailments, Alzheimer disease, and Cancer.

REFERENCES:
patent: 5804594 (1998-09-01), Murad
patent: 5885597 (1999-03-01), Botknecht et al.
patent: 5925377 (1999-07-01), Gerth et al.
patent: 6210701 (2001-04-01), Darland et al.
patent: 6352712 (2002-03-01), Lukaczer et al.
patent: 6399089 (2002-06-01), Yegorova et al.
patent: 6534086 (2003-03-01), Krumhar
patent: 6602517 (2003-08-01), Darland et al.
patent: 6617349 (2003-09-01), Green et al.
patent: 6949260 (2005-09-01), Krumhar
patent: 6979470 (2005-12-01), Babish et al.
patent: 7138149 (2006-11-01), Cho
patent: 2002/0051826 (2002-05-01), Darland
patent: 2003/0068383 (2003-04-01), Patterson et al.
patent: 2004/0028675 (2004-02-01), Ziegler
patent: 2004/0052873 (2004-03-01), Qazi et al.
patent: 2004/0086581 (2004-05-01), Jones
patent: 2004/0121028 (2004-06-01), Qazi et al.
patent: 2004/0247700 (2004-12-01), Babish et al.
patent: 2005/0265990 (2005-12-01), Talbott
patent: 2005/0282772 (2005-12-01), Gokaraju et al.
patent: 2006/0040000 (2006-02-01), Gokaraju et al.
patent: 2006/0240037 (2006-10-01), Fey et al.
patent: 2006/0246115 (2006-11-01), Rueda et al.
Jurna I, Schmerz, Analgetische und analgesie-potenzietende Wirkung von B-Vitaminen, Medizinische Fakultat der Universitat des Saarlandes, Apr. 20, 1998, pp. 136-141, vol. 12, No. 2.
Gokhale, Leela B., Curative treatment of primary (spasmodic) dysmenorrhoea, Indian J. Med. Res., Apr. 1996, pp. 227-231, vol. 103.
Kandarkar, et al., Subchronic oral heptotoxicity of turmeric in mice—Histopathological and ultrastructural studies, Indian Journal of Experimental Biology, Jul. 1998, pp. 675-679, vol. 36.
Bender, David A., Novel functions of vitamin B6, Proceedings of the Nutrition Society, 1994, pp. 625-630, vol. 53.
Chandra, et al., Regulation of Immune Responses by Vitamin B6, NY Acad Sci, 1990, pp. 404-423, vol. 585.
Trakatellis, et al., Pyridoxine deficiency: new approaches in immunosuppression and chemotherapy, Postgrad Med J, 1997; pp. 617-622, vol. 73.
Shibata, et al., Effects of Vitamin B6 Deficiency on the Conversion Ratio of Tryptophan to Niacin, Biosci. Biotech. Biochem, 1995, pp. 2060-2063, vol. 59, No. 11.
Babu, et al., Hypolipidemic action of curcumin, the active principle of termeric (Curcuma longa) in streptozotocin induced diabetic rats, Molecular and Cellular Biochemistry, 1997, pp. 169-175, vol. 166.
Aggarwal, et al., Anticancer Potential of Curcumin: Preclinical and Clinical Studies, 2003, Anticancer Research, pp. 363-698, vol. 23.
Chainani-Wu, Nita, Safety and Anti-Inflammatory Activity of Curcumin: A Component of Tumeric (Curcuma longa), The Journal of Alternative and Complementary Medicine, 2003, pp. 161-168, vol. 9, No. 1.
Poeckel, et al., Boswellic Acids: Biological Actions and Molecular Targets, Current Medicinal Chemistry, 2006, pp. 3359-3369, vol. 13.
Kimmatkar, et al., Efficacy and tolerability ofBoswellia serrataextract in treatement of osteoarthritis of knee—A randomized double blind placebo controlled trial, Phytomedicine, 2003, pp. 3-4, vol. 10.
Wochenschr, Wien Med, Boswelliasauren(Inhaltsstoffe des Weihrauchs) als wirksame Prinzipien zur Behandlung chronisch entzundlicher Erkrankungen, Aus dem Lehrstuhl Pharmakologic fur Naturwissenschaftler, 2002, pp. 373-378, vol. 152, No. 15-16.
Quercetin, University of Maryland Medical Center, Center of integrative medicine, http://www/altmed/ConSupplements/Quercetines.htm, Date: 2008.
Kelly, Gregory S., Bromelain: A Literature Review and Discussion of its Therapeutic Applications, Alternative Medicine Review, 1996, pp. 243-257, vol. 1, No. 4.
Orsini, et al., Bromelain, Plast Reconstr Surg, 2006, pp. 1640-1644, vol. 118, No. 7.
Masse, et al., A Cartilage Matrix Deficiency Experimentally Induced by Vitamin B6 Deficiency, Proc Soc Exp Biol Med., 1998, pp. 97-101, vol. 217, No. 1.
Sanderson, et al., Serum Pyridoxal in patients with rheumatoid arthritis, Ann. rheum. Dis., 1976, pp. 177-180, vol. 35, No. 2.
Ammon, HP, Boswellic Acids in Chronic Inflammatory Diseases, Dept. of Pharmacology, Institute of Pharmaceutical Sciences, University of Tuebingen, Tuebingen, Germany. sekretariat.ammon@uni-tuebingen.de, Date: 2006.
Reichling, et al., Dietary support with Boswellia resin in canine inflammatory joint and spinal disease, 2004, pp. 71-79, vol. 146, No. 2.
Shakibaei, et al., Suppression of NG-kB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chonodrocytes: Implications for the treatment of osteoarthritis, Biochem Pharmacol., 2007, pp. 1434-1445, vol. 73, No. 9.
Akhtar, et al., Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee—a double-blind prospective randomized study, Clin Rheumatol., 2004, pp. 410-415, vol. 23, No. 5.
Walker, et al., Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults, Phytomedicine, 2002, pp. 681-686, vol. 9, No. 8.
Sico, Domenic A., Loop Diuretic Therapy, Thiamine Balance, and Heart Failure, pp. 244-247, vol. 13, No. 4, Date: 2007.
Suter, et al., Diuretics and Vitamin B1: Are Diuretics a Risk Factor for Thiamin Malnutrition?, Nutr Rev., 2000, pp. 319-323, vol. 58, No. 10.
Oliveira, et al., Abolition of reperfusion-induced arrhythmias in hearts from thiamine-deficient rats, Am J Physical Heart Circ Physiol, 2007, pp. H394-H401, vol. 293.
Allard, et al., The management of conditioned nutritional requirements in heart failure, Heart Fail Rev, 2006, pp. 75-825, vol. 11.
Lin, et al., Low Pyridoxal 5′ -phosphate is associated with increased risk of coronary artery disease, Applied nutritional investigation, 2006, pp. 1146-1151, vol. 22.
Endo, et al., Antioxidant activity of vitamin B6 delays homocysteine-induced atherosclerosis in rats, British Journal of Nutrition, 2006, pp. 1088-1093, vol. 95.
Friso, et al., Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk 1, 2, 3, Am J Clin Nutr., 2004, pp. 992-998, vol. 79, No. 6.
Harper, Clive, The neurotoxicity of alcohol, Hum Exp Toxicol., 2007, pp. 251-251, vol. 26, No. 3.
Savage, et al., Selective septohippocampal—but not forebrain amygdalar—cholinergic dysfunction in diencephalic amnesia, Brain Res., 2007, pp. 210-219, vol. 1139.
Wang, et al., Thiamine Deficiency Induces Endoplasmic Reticulum Stress in Neurons, Neuroscience, 2007, pp. 1045-1056, vol. 144, No. 3.
Vemuganti, et al., Gene expression changes in thalamus and inferior colliculus associated with inflammation, cellular stress, metabolism and structural damage in thiamine deficiency, Eur J Neurosci., 2006, pp. 1172-1188, vol. 23, No. 5.
Krishna, et al., Effect of pyridoxine deficiency on the structural and functional development of hippocampus, Indian J Physiol Pharmacol, 2004, pp. 304-310, vol. 48, No. 3.
Tang, et al., Vitamin B-6 Deficiency Prolongs the Time Course of Evoked Dopamine Release from Rat Striatum 1,2, J Nutr., 2004, pp. 3350-3354, vol. 134, No. 12.
Hvas, et al., Vitamin B6 Level Is Associated with Symptoms of Depression, Psychother Psychosom., 2004, pp. 340-343, vol. 73, No. 6.
Khajavi, et al., Oral Curcumin Mitigates the Clinical and Neuropathological Phenotype of the Trembler-J Mouse: A Po

Affiliated with

Also associated with

Rating

Supplements for pain management does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Supplements for pain management, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Supplements for pain management will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2663112